Antithymocyte Immunoglobulin

3 trials 1 recruiting LOncology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

3 Sponsors

9 Countries

Phase III

Phase II

Phase III: 2 Phase II: 1

Indications tested

Kidney transplant rejection 1 Relapsing-remitting multiple sclerosis 1

Sponsors using this IMP

Eledon Pharmaceuticals Inc. 1 Helse Bergen HF 1 Vaestra Goetalandsregionen 1

All trials

3 total

Studying Conditioning Regimen In Pediatric Transplantation -AML Recruiting

2023-505512-37-00 Phase III 6 countries Vaestra Goetalandsregionen
RAM-MS Ended

2024-510630-40-00 Phase III 4 countries Helse Bergen HF
BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidne… Ended

2023-503336-41-00 Phase II 3 countries Eledon Pharmaceuticals Inc.

Showing 1–3 of 3 trials

← All drugs A–Z